The adenosine receptors present on the plasma membrane of chromaffin cells are of the A2b subtype.
The adenosine receptors in the plasma membrane of chromaffin cells from bovine adrenal medulla were characterized. The presence of A1 receptors was discounted owing to the absence of R-[3H]phenylisopropyladenosine (R-PIA) and [3H]8-cyclopentyl-1,3-dipropylxanthine ([3H]-DPCPX) binding. The binding of the specific A2a ligand CGS-21680 was low. In contrast, the binding of 5'-(N-[3H]-ethylcarboxamidoadenosine ([3H]NECA) was relatively high (1.7 pmol/mg of protein at a ligand concentration up to 90 nM). This binding did not correspond to non-adenosine receptor NECA binding sites because the specific [3H]-NECA binding was similar when unlabeled adenosine, NECA, or R-PIA was used to measure the nonspecific binding. The rank order of potency of different ligands for the displacement of specific [3H]NECA binding was DPCPX greater than NECA greater than chloroadenosine greater than R-PIA greater than theophylline = CGS-21680. These results indicate that the receptors present on the plasma membrane of chromaffin cells are exclusively of the A2b subtype.
Casadó
V
V
Departament de Bioquimica i Fisiologia, Unitat de Bioquimica i Biologia Molecular A. Martí i Franquès 1, Barcelona, Spain.
Casillas
T
T
Mallol
J
J
Canela
E I
EI
Lluis
C
C
Franco
R
R
D015762:2-Chloroadenosine / Q000378:metabolism; D000241:Adenosine / Q000031:analogs & derivatives / Q000378:metabolism; D019830:Adenosine-5'-(N-ethylcarboxamide); D000818:Animals; D002417:Cattle; D002458:Cell Fractionation; D002462:Cell Membrane / Q000737:chemistry / Q000378:metabolism / Q000648:ultrastructure; D002838:Chromaffin System / Q000737:chemistry / Q000166:cytology* / Q000648:ultrastructure; D010660:Phenylisopropyladenosine / Q000378:metabolism; D011869:Radioligand Assay; D011983:Receptors, Purinergic / Q000032:analysis* / Q000737:chemistry / Q000378:metabolism; D014316:Tritium; D014665:Vasodilator Agents / Q000378:metabolism; D014970:Xanthines / Q000378:metabolism
D011983:Receptors, Purinergic; D014665:Vasodilator Agents; D014970:Xanthines; D014316:Tritium; D015762:2-Chloroadenosine; D010660:Phenylisopropyladenosine; D019830:Adenosine-5'-(N-ethylcarboxamide); C051360:1,3-dipropyl-8-cyclopentylxanthine; D000241:Adenosine